ndd Medical Technologies

Executive Summary

ndd Medical Technologies is a Swiss medical device company founded in 1992 and headquartered in Zurich, specializing in innovative pulmonary function testing (PFT) solutions. The company is a global leader in portable spirometers and complete PFT machines, known for the EasyOne series, which offers accuracy, reliability, and ease of use for clinical settings. ndd’s mission is to enable earlier diagnosis and better management of respiratory diseases such as COPD through advanced point-of-care lung function testing. With a focus on portable and user-friendly devices, ndd addresses the growing demand for accessible diagnostics in primary care, pulmonary clinics, and home settings. The company has established a strong reputation among healthcare professionals and has a global distribution network. ndd’s growth is driven by increasing prevalence of respiratory diseases, the shift toward point-of-care testing, and innovation in digital health integration. The company remains privately held and has not disclosed recent funding or valuation, suggesting a focus on organic growth. Potential catalysts include the launch of a next-generation EasyOne device with enhanced connectivity features, FDA clearance for a home-use spirometer that could expand its addressable market, and strategic partnerships with pharmaceutical companies to bundle diagnostics with COPD therapies. These initiatives could strengthen ndd’s market leadership and drive revenue growth.

Upcoming Catalysts (preview)

• Q4 2026Launch of next-generation EasyOne spirometer with enhanced connectivity and remote monitoring features80% success
• Q2 2027FDA 510(k) clearance for a home-use spirometer targeting COPD and asthma management60% success
• Q3 2026Strategic partnership with a major respiratory therapeutics company for integrated diagnostics50% success